Ausgabe 2/2009
Inhalt (27 Artikel)
Lymphatic venous anastomosis (LVA) for treatment of secondary arm lymphedema. A prospective study of 11 LVA procedures in 10 patients with breast cancer related lymphedema and a critical review of the literature
R. J. Damstra, H. G. J. Voesten, W. D. van Schelven, B. van der Lei
Ten years of HER2-directed therapy: still questions after all these years
Ian E. Krop, Eric P. Winer
Donor-derived breast cancer in a bone marrow transplantation recipient
Vassilis Golfinopouloss, George Pentheroudakis, Smaragda Kamakari, Vasiliki Metaxa-Mariatou, Nicholas Pavlidis
Donor-derived breast cancer in a bone marrow transplantation recipient
Vassilis Golfinopoulos, George Pentheroudakis, Smaragda Kamakari, Vasiliki Metaxa-Mariatou, Nicholas Pavlidis
TRAIL induces apoptosis in triple-negative breast cancer cells with a mesenchymal phenotype
Monzur Rahman, Sean R. Davis, Janet G. Pumphrey, Jing Bao, Marion M. Nau, Paul S. Meltzer, Stanley Lipkowitz
Integrated gene expression profile predicts prognosis of breast cancer patients
Lian-Fang Li, Xiao-Jing Xu, Ying Zhao, Zhe-Bing Liu, Zhen-Zhou Shen, Wei-Rong Jin, Zhi-Ming Shao
Gene expression meta-analysis identifies chromosomal regions and candidate genes involved in breast cancer metastasis
Mads Thomassen, Qihua Tan, Torben A. Kruse
Gene expression meta-analysis identifies chromosomal regions and candidate genes involved in breast cancer metastasis
Mads Thomassen, Qihua Tan, Torben A. Kruse
TSC22D1 and PSAP predict clinical outcome of tamoxifen treatment in patients with recurrent breast cancer
Danielle Meijer, Maurice P. H. M. Jansen, Maxime P. Look, Kirsten Ruigrok-Ritstier, Iris L. van Staveren, Anieta M. Sieuwerts, Ton van Agthoven, John A. Foekens, Lambert C. J. Dorssers, Els M. J. J. Berns
Lymphatic and angiogenic characteristics in breast cancer: morphometric analysis and prognostic implications
Rabab A. A. Mohammed, Ian O. Ellis, Somaia Elsheikh, Emma C. Paish, Stewart G. Martin
Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifen
Marleen Kok, Sabine C. Linn, Ryan K. Van Laar, Maurice P. H. M. Jansen, Teun M. van den Berg, Leonie J. M. J. Delahaye, Annuska M. Glas, Johannes L. Peterse, Michael Hauptmann, John A. Foekens, Jan G. M. Klijn, Lodewyk F. A. Wessels, Laura J. Van’t Veer, Els M. J. J. Berns
Deleterious CHEK2 1100delC and L303X mutants identified among 38 human breast cancer cell lines
Marijke Wasielewski, Pejman Hanifi-Moghaddam, Antoinette Hollestelle, Sofia D. Merajver, Ans van den Ouweland, Jan G. M. Klijn, Stephen P. Ethier, Mieke Schutte
Elevated chemokine receptor CXCR4 expression in primary tumors following neoadjuvant chemotherapy predicts poor outcomes for patients with locally advanced breast cancer (LABC)
Neal T. Holm, Fleurette Abreo, Lester W. Johnson, Benjamin D. L. Li, Quyen D. Chu
HER-2/neu expression in primary and metastatic breast cancer
Elyse E. Lower, Eleanor Glass, Robbin Blau, Stacy Harman
Comparison among different classification systems regarding the pathological response of preoperative chemotherapy in relation to the long-term outcome
Tadahiko Shien, Chikako Shimizu, Kunihiko Seki, Taro Shibata, Takashi Hojo, Masashi Ando, Tsutomu Kohno, Noriyuki Katsumata, Sadako Akashi-Tanaka, Takayuki Kinoshita, Yasuhiro Fujiwara
Amenorrhea in premenopausal women on the doxorubicin-and-cyclophosphamide-followed-by-docetaxel arm of NSABP B-30 trial
Sandra M. Swain, Stephanie R. Land, Marcie W. Ritter, Joseph P. Costantino, Reena S. Cecchini, Eleftherios P. Mamounas, Norman Wolmark, Patricia A. Ganz
Long-term “protective” effect of aromatase inhibitors on the endometrium of postmenopausal breast cancer patients
O. Markovitch, R. Tepper, A. Fishman, R. Aviram, I. Cohen
Racial and ethnic differences in mammography use among U.S. women younger than age 40
Julie M. Kapp, A. Blythe Ryerson, Steven S. Coughlin, Trevor D. Thompson
Prevalence and risk of depressive symptoms 3–4 months post-surgery in a nationwide cohort study of Danish women treated for early stage breast-cancer
Søren Christensen, Robert Zachariae, Anders Bonde Jensen, Michael Væth, Susanne Møller, Joan Ravnsbæk, Hans von der Maase
Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA
Mary Jo Lund, Katrina F. Trivers, Peggy L. Porter, Ralph J. Coates, Brian Leyland-Jones, Otis W. Brawley, Elaine W. Flagg, Ruth M. O’Regan, Sheryl G. A. Gabram, J. William Eley
Evaluation of the BRCA1 interacting genes RAP80 and CCDC98 in familial breast cancer susceptibility
Ana Osorio, Alicia Barroso, Maria J. García, Beatriz Martínez-Delgado, Miguel Urioste, Javier Benítez
Germline RAP80 mutations and susceptibility to breast cancer
Mohammad Reza Akbari, Parviz Ghadirian, Andre Robidoux, Maryam Foumani, Yulong Sun, Robert Royer, Inuk Zandvakili, Henry Lynch, Steven A. Narod
Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White women
Kathleen A. Meeske, Jane Sullivan-Halley, Ashley W. Smith, Anne McTiernan, Kathy B. Baumgartner, Linda C. Harlan, Leslie Bernstein
BRCA1 E1644X: a deleterious mutation in an African American individual with early onset breast cancer
S. Eric Martin, Mark Sausen, Abraham Joseph, David D. Biggs, Brewster F. Kingham, Eric S. Martin
The surgical margin status after breast-conserving surgery: discussion of an open issue
Alberto Luini, Joel Rososchansky, Giovanna Gatti, Stefano Zurrida, Pietro Caldarella, Giuseppe Viale, Gabriela Rosali dos Santos, Antonio Frasson
Primary endocrine therapy in locally advanced breast cancers—the Nottingham experience
J. Mathew, A. Agrawal, K. S. Asgeirsson, S. A. Buhari, L. R. Jackson, K. L. Cheung, J. F. R. Robertson
Pooled analysis of diarrhea events in patients with cancer treated with lapatinib
John P. Crown, Harold A. Burris III, Fran Boyle, Suzanne Jones, Maria Koehler, Beth O. Newstat, Roma Parikh, Cristina Oliva, Alaknanda Preston, Julie Byrne, Steve Chan